Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04244370 · ClinicalTrials.gov registry record · NA
Caterpillar™ Arterial Embolization Device Post-Market Study
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT04244370 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 50 participants.
The verdict
NCT04244370, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the performance and safety of the Caterpillar™ Arterial Embolization Device when used for arterial embolization in the peripheral vasculature in a real world, on-label application.
Interventions
- DEVICE Caterpillar™ Arterial Embolization Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-04-30 |
| Est. Completion | 2022-08-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04244370
The ClinicalTrials.gov registry entry for NCT04244370 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Caterpillar™ Arterial Embolization Device is the first listed.
NCT04244370 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04244370 about?
NCT04244370 is a clinical study titled "Caterpillar™ Arterial Embolization Device Post-Market Study". The primary objective of this study is to evaluate the performance and safety of the Caterpillar™ Arterial Embolization Device when used for arterial embolization in the peripheral vasculature in a real world, on-label application.
What is the current status of trial NCT04244370?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2020-04-30. Estimated completion is 2022-08-12.
What interventions are being tested in trial NCT04244370?
The interventions under investigation include: Caterpillar™ Arterial Embolization Device (DEVICE).
Who is sponsoring clinical trial NCT04244370?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.